HISUN PHARM HANGZHOU FDA Approval ANDA 212250

ANDA 212250

HISUN PHARM HANGZHOU

FDA Drug Application

Application #212250

Application Sponsors

ANDA 212250HISUN PHARM HANGZHOU

Marketing Status

Prescription001

Application Products

001POWDER;INTRAVENOUS500MG/VIAL0DAPTOMYCINDAPTOMYCIN

FDA Submissions

UNKNOWN; ORIG1AP2021-04-21STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

HISUN PHARM HANGZHOU
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212250
            [companyName] => HISUN PHARM HANGZHOU
            [docInserts] => ["",""]
            [products] => [{"drugName":"DAPTOMYCIN","activeIngredients":"DAPTOMYCIN","strength":"500MG\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/21\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-04-21
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.